EFPIA - NEWSLETTER

EFPIA Newsletter 16 March 2023

EU Competitiveness: Mind the gap between rhetoric and reality

EU Pharmaceutical Legislation: How can we move forward with a pivotal piece of legislation that will shape our health, science, jobs and growth for the next 20-30 years, without a full assessment of the impact on European competitiveness?

News

16 March 2023 EBC & EFPIA launch RETHINKING Alzheimer’s disease White Paper

On the occasion of the Brain Awareness Week, the European Brain Council (EBC) and EFPIA launched the RETHINKING Alzheimer’s...

09 February 2023 Industry Statement on the earthquakes in Turkey and Syria

Industry will continue to work with partners and authorities across Europe to provide further support where possible....

Blogs

16 March 2023 A modernised EU Variation Framework for enhancing the life of European patients

Regulatory Road to Innovation

16 March 2023 Cross-stakeholder action is key to ensuring continued patient access to improved treatments...

Endpoints that measure time to disease progression or tumour shrinkage may provide a better approach to assessing novel...

16 March 2023 An inclusive discussion to design an ideal PULL mechanism (Guest Blog)

A silent pandemic is around the corner: antimicrobial resistance. The problem? The innovation engine, meant to provide...

Events

16 MAR 2023

GetReal Institute Annual Conference 2023 Utrecht, Netherlands

A European Outlook on Real World Evidence in a Global Context

Learn more →

22 MAR 2023

DIA Europe 2023 - 35th Anniversary of the event Basel, Switzerland

35th Anniversary of the event

Learn more →

22 MAR 2023

Healthier Hearts Stockholm + digital

Why boosting cardiovascular health policy is critical for Europe

Learn more →

30 MAR 2023

The Estimands Academy for Trial Teams: Bringing estimands to life through case studies... Online

Webinar 4 - Proposing Estimands from Different Perspectives: Patient, Clinician, Regulator, Health Technology Assessor...

Learn more →

What we are reading

Joint health checks for CVD and diabetes – Exhibition at the European Parliament 16 March 2023 (International Diabetes Federation)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶